Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke

Ischemic stroke (IS) is a serious cerebrovascular disease with high morbidity and disability worldwide. Despite the great efforts that have been made, the prognosis of patients with IS remains unsatisfactory. Notably, recent studies indicated that mesenchymal stem cell (MSCs) therapy is becoming a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yinghan, Peng, Yucong, Zeng, Hanhai, Chen, Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219421/
https://www.ncbi.nlm.nih.gov/pubmed/34221026
http://dx.doi.org/10.1155/2021/9923566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219421/
https://www.ncbi.nlm.nih.gov/pubmed/34221026
http://dx.doi.org/10.1155/2021/9923566

Ejemplares similares